All Stories

  1. Oligopeptide Transporters of Nonencapsulated Streptococcus pneumoniae Regulate CbpAC and PspA Expression and Reduce Complement-Mediated Clearance
  2. If Not Now, When? Nonserotype Pneumococcal Protein Vaccines
  3. Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid
  4. Prophylactic inhibition of colonization by Streptococcus pneumoniae with the secondary bile acid metabolite deoxycholic acid
  5. Otitis Media and Ear Infections: Bacteria
  6. Hydrogen Peroxide Production by Streptococcus pneumoniae Results in Alpha-hemolysis by Oxidation of Oxy-hemoglobin to Met-hemoglobin
  7. Hydrogen peroxide production by Streptococcus pneumoniae results in alpha-hemolysis by oxidation of oxy-hemoglobin to met-hemoglobin
  8. Mucosal Vaccines for Streptococcus pneumoniae
  9. The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA
  10. Selective pressure: Rise of the nonencapsulated pneumococcus
  11. Pulmonary Disease Associated With Nonencapsulated Streptococcus pneumoniae
  12. Pseudomonas aeruginosa and Streptococcus pneumoniae coinfection
  13. Invasive Potential of Nonencapsulated Streptococcus pneumoniae
  14. Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae
  15. Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?
  16. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media
  17. NonencapsulatedStreptococcus pneumoniae: Emergence and Pathogenesis
  18. Nonencapsulated Streptococcus pneumoniae as a cause of chronic adenoiditis
  19. Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization
  20. Nonencapsulated Streptococcus pneumoniae Cause Acute Otitis Media in the Chinchilla That Is Enhanced by Pneumococcal Surface Protein K
  21. Choline-Binding Proteins
  22. Draft Genome Sequences of Five Multilocus Sequence Types of Nonencapsulated Streptococcus pneumoniae
  23. The Cholesterol-Dependent Cytolysin Pneumolysin from Streptococcus pneumoniae Binds to Lipid Raft Microdomains in Human Corneal Epithelial Cells
  24. Serine Protease PKF of Acinetobacter baumannii Results in Serum Resistance and Suppression of Biofilm Formation
  25. PspK of Streptococcus pneumoniae Increases Adherence to Epithelial Cells and Enhances Nasopharyngeal Colonization
  26. 66-P
  27. Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis
  28. Serum resistance and biofilm formation in clinical isolates ofAcinetobacter baumannii
  29. Cross-Sectional Study of Nasopharyngeal Carriage of Streptococcus pneumoniae in Human Immunodeficiency Virus-Infected Adults in the Conjugate Vaccine Era
  30. Protection from Streptococcus pneumoniae Keratitis by Passive Immunization with Pneumolysin Antiserum
  31. Factor H Binding to PspC of Streptococcus pneumoniae Increases Adherence to Human Cell Lines In Vitro and Enhances Invasion of Mouse Lungs In Vivo
  32. Characterization of Streptococcus pneumoniae isolated from children with otitis media
  33. Immunization with PspA Incorporated into a Poly(Ethylene Oxide) Matrix Elicits Protective Immunity against Streptococcus pneumoniae
  34. Localization of PcsB of Streptococcus pneumoniae and Its Differential Expression in Response to Stress
  35. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA
  36. Gene expression profiling of the response of Streptococcus pneumoniae to penicillin
  37. Tex, a putative transcriptional accessory factor, is involved in pathogen fitness in Streptococcus pneumoniae
  38. Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H
  39. 57-P
  40. In Vivo Binding of Complement Regulator Factor H by Streptococcus pneumoniae
  41. THP-1 Monocytes Up-Regulate Intercellular Adhesion Molecule 1 in Response to Pneumolysin from Streptococcus pneumoniae
  42. Impact of peripheral blood IL-18 gene early expression on kidney allograft long-term outcome
  43. Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H
  44. Pneumococcal Disease
  45. Relative Roles of Genetic Background and Variation in PspA in the Ability of Antibodies to PspA To Protect against Capsular Type 3 and 4 Strains of Streptococcus pneumoniae
  46. Pneumolysin-Dependent and -Independent Gene Expression Identified by cDNA Microarray Analysis of THP-1 Human Mononuclear Cells Stimulated by Streptococcus pneumoniae
  47. Genetic Immunization with the Region Encoding the α-Helical Domain of PspA Elicits Protective Immunity againstStreptococcus pneumoniae
  48. Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae
  49. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae
  50. Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6BStreptococcus pneumoniae
  51. Truncated Streptococcus pneumoniae PspA Molecules Elicit Cross-Protective Immunity against Pneumococcal Challenge in Mice
  52. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
  53. Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae
  54. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae
  55. Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies
  56. Role of Pneumococcal Surface Protein A in the Virulence of Streptococcus pneumoniae
  57. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies
  58. Monoclonal Antibodies against Surface Components of Streptococcus pneumoniae
  59. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae